Showing 31 - 40 of 92 results

Showing Results for: “Covid-19”

Leading Diabetes Advocacy Groups Urge CDC to Include Americans with Diabetes in Those Prioritized for COVID-19 Vaccine Boosters

Today, the American Diabetes Association ® and 14 other leading voluntary health organizations and medical societies concerned with diabetes urged the Centers for Disease Control and Prevention (CDC) to consider the health risks people with diabetes are facing with COVID-19 as the agency develops guidance on special patient populations who may benefit from additional COVID-19 vaccine doses. Combined, these groups advocate on behalf of the 122 million Americans with diabetes and prediabetes. This week, it was announced that the Food and Drug Administration (FDA) and CDC will be releasing

New Study Shows Hospitalization Rates for New Onset Pediatric Type 2 Diabetes Doubled During COVID-19 Pandemic

Initial data indicate that children presented with higher acuity compared to the previous year New data show that the incidence and acuity of type 2 diabetes in children increased significantly during the peak of the COVID-19 pandemic, with more pediatric patients hospitalized from March to December 2020 compared to the same time period in 2019. Findings from the retrospective chart review were presented as a late-breaking poster session at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Stay-at-home orders due to the COVID-19 pandemic exacerbated risk

29 Patient Organizations Urge Lawmakers to Take Bold, Immediate Action to Protect Those Most Vulnerable to COVID-19

Twenty-nine organizations representing millions of patients diagnosed with serious health conditions urge the U.S. Senate to immediately pass the U.S. House-approved coronavirus bill and take additional critical steps. In a letter to Senate Majority Leader Mitch McConnell and Senate Minority Leader Chuck Schumer, the organizations emphasize the importance of enacting the Families First Coronavirus Response Act (H.R. 6201). Public health experts warn that patients with serious, chronic conditions face heightened risk of sickness and death if infected with the novel coronavirus. For these

The American Diabetes Association Praises Introduction of Affordable Insulin for the COVID-19 Emergency Act and the Minority Diabetes Initiative Act

Waters Bills Would Eliminate Cost-Sharing for Insulin-Dependent Seniors and Provide Needed Grants for Diabetes Prevention, Care and Treatment The American Diabetes Association® (ADA) announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act (H.R. 2179) and the Minority Diabetes Initiative Act (H.R. 2178), both introduced this week by Representative Maxine Waters (D-CA-43). The ADA calls on all Members of Congress to co-sponsor both pieces of legislation. Currently, both bills have more than 30 cosponsors. The Affordable Insulin for the COVID-19 Emergency Act

Over 100 Leading Advocacy Groups Demand Congress Address Lack of COVID-19 Testing in Nation’s Underserved Communities

American Diabetes Association, Black Lives Matter, NAACP, AARP and others urge Congress to make testing more accessible through mobile units, community health workers and other means The American Diabetes Association® (ADA) today, along with over 100 other national groups, sent a letter to congressional leaders calling for them to focus their efforts for increasing testing in the most vulnerable communities as they continue to be hardest hit by the COVID-19 pandemic. Groups such as Black Lives Matter Global Network, the NAACP, AARP, Boys and Girls Club of America, the American Nurses

American Diabetes Association® and Sun Life educate advocates on diabetes management during COVID-19 at virtual Call to Congress

People with diabetes are three times as likely to need hospitalization if infected with COVID-19 With the diabetes community at greater risk for complications during the COVID-19 pandemic, the American Diabetes Association® (ADA) and Sun Life partnered to reinvent this year’s annual Call to Congress to educate advocates on COVID-19 and diabetes, and how to support people with diabetes during the pandemic. Usually an in-person gathering of ADA Advocates on Capitol Hill, the recent virtual town hall event informed and engaged the diabetes advocate community about legislative goals specific to

American Diabetes Association Presents Latest COVID-19 Findings with Five Comprehensive Panel Symposia at the 81st Scientific Sessions

Leading diabetes researchers and clinicians from around the world highlight impact of pandemic on patient outcomes and key learnings The American Diabetes Association ® (ADA) is kicking off the virtual 81st Scientific Sessions tomorrow and will feature five COVID-19 Symposia, highlighting cutting-edge science and the latest diabetes developments learned during the initial phases of the pandemic. The Symposia will be presented over the course of the annual meeting taking place June 25–29. This latest research comes at a time when individuals with diabetes, and other related underlying health